KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SiriusPoint (SPNT) Cash & Equivalents (2016 - 2025)

SiriusPoint's Cash & Equivalents history spans 14 years, with the latest figure at $731.2 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 7.21% year-over-year to $731.2 million; the TTM value through Dec 2025 reached $731.2 million, up 7.21%, while the annual FY2025 figure was $731.2 million, 7.21% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $731.2 million at SiriusPoint, up from $582.4 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $1.0 billion in Q2 2021 and bottomed at $582.4 million in Q3 2025.
  • The 5-year median for Cash & Equivalents is $731.8 million (2025), against an average of $763.9 million.
  • The largest annual shift saw Cash & Equivalents skyrocketed 109.16% in 2021 before it decreased 29.63% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $999.8 million in 2021, then dropped by 29.46% to $705.3 million in 2022, then soared by 37.42% to $969.2 million in 2023, then fell by 29.63% to $682.0 million in 2024, then increased by 7.21% to $731.2 million in 2025.
  • Per Business Quant, the three most recent readings for SPNT's Cash & Equivalents are $731.2 million (Q4 2025), $582.4 million (Q3 2025), and $732.4 million (Q2 2025).